Physician profile
Evan Siegall
NPI 1215248711
$1,963.23
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $52.45 · 2020: $124 · 2021: $138 · 2022: $309 · 2023: $160 · 2024: $1,179.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $814 · Food and Beverage: $525.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $813.81 |
| Food and Beverage | $525.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Team 1, LLC | $988.39 | 2024 | |
| Smith+Nephew, INC. | $363.68 | 2019-2024 | Stravix, Grafix Pl |
| Abbvie INC. | $128.30 | 2022 | |
| Nuvasive, INC. | $123.07 | 2022 | |
| Medtronic, INC. | $110.51 | 2022-2024 | O-Arm, Unid_pass |
| Davol INC. | $60.73 | 2024 | Arista Ah Flexitip |
| Pacira Pharmaceuticals Incorporated | $56.71 | 2021-2023 | Iovera |
| Ermi LLC | $30.00 | 2023 | |
| Orthopediatrics Corp. | $26.51 | 2019 | |
| Arthrex, INC. | $24.00 | 2024 | |
| Convatec INC. | $20.76 | 2024 | |
| Fidia Pharma USA INC. | $17.65 | 2023 | Hym/Hyn |
| Ultragenyx Pharmaceutical INC. | $12.92 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Evan Siegall listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.